pH Adjustment in Pharmaceutical Production

Article

Sponsored Content

ITW Reagents is fully integrated by AppliChem GmbH and PanReac Química SLU companies, under unique commercial brand PanReac AppliChem since 2014.

 

With 75 years’ of experience, ITW Reagents is a Chemical producer of high quality chemicals for pharmaceutical manufacturing processes.

 

One of these processes is the pH adjustment in pharmaceutical production. In this process it is important to use reagents of the appropriate quality grade. Laboratory products are not suitable for this particular application as some important certificates requested by authorities will be missing.

 

PanReac AppliChem offers the right product for your needs with the necessary documentation.

 

Main advantages:

  • Acids and bases at different concentrations for different applications.


  • Pharma grade: specifications according to main pharmacopoeias (USP and Ph. Eur.).


  • Documents and certificates that regulatory bodies require: BSE / TSE, GMO, residual solvents, allergens, trace metal residues, etc.


  • Different pack sizes are available to adjust your particular needs.

 

 

Our product range cover different concentrations of hydrochloric acid, acetic acid, ortho-phosphoric acid, sodium hydroxide and ammonia, among others.

 

ITW Reagents has two production plants (in Barcelona, Spain and Darmstadt, Germany) and three logistics centers of 20,000 m2 (in Barcelona, Spain; Darmstadt, Germany and Milan, Italy) to address our client needs.

 

For further information contact us at customerservice.es@itwreagents.com

 

Contact Details:

Company name: ITW REAGENTS
Website: www.itwreagents.com
E-mail: customerservice.es@itwreagents.com

Recent Videos
Mike Baird from Schlafender Hase gives his predictions for how AI and ML may find use in the industry moving forwards and provides some predictions about M&A and the changing US government administration.
Mike Baird from Schlafender Haser discusses industry trends from 2024 and those expected to have an impact in 2025 from the perspective of a software developer.
Preeya Beczek from Beczek.COM gives her thoughts on the areas to watch with the new US administration and how Europe might be finalizing preparations for previous legislative changes
Drug Digest: Challenges and Triumphs in Next-Generation Biotherapeutic Development
Related Content